Pharmaceutical News

Pharmaceutical News & Media

Valeant Pharmaceuticals International, Inc. (NYSE: VRX/TSX: VRX) completed its acquisition of Salix Pharmaceuticals, Ltd. ("Salix") on April 1, 2015.

Read the latest Investor Relations information from Valeant

Salix Pharmaceuticals Announces Exclusive Sponsorship of the 2016 Gut Microbiome Conference

SWB11-0814



Explore Career Opportunities with Salix